Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 250

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly

Open access
Shirvani, Shervin M., Jiang, Jing, Chang, Joe Y., Welsh, James W., Gomez, Daniel R., Swisher, Stephen, Buchholz, Thomas A., Smith, Benjamin D.·2012·International Journal of Radiation Oncology*Biology*Physics

Abstract

Purpose Early-stage non-small cell lung cancer (NSCLC) incidence among older adults is expected to increase due to demographic trends and CT-based screening, yet optimal treatment in the elderly remains controversial. Using the SEER-Medicare cohort spanning 2001–2007, we compared survival outcomes associated with five strategies used in contemporary practice: lobectomy, sublobar resection, conventional radiation, stereotactic ablative radiotherapy (SABR) and observation. Methods and Materials Treatment strategy and covariates were determined in 10,923 patients age≥66 with stage IA-IB NSCLC. Cox regression, adjusted for patient and tumor factors, compared overall and disease-specific survival for the five strategies. In a second, exploratory analysis, propensity-score matching was used for comparison of SABR with other options. Results Median age was 75 years and 29% had moderate-to-severe comorbidities. Treatment distribution was lobectomy (59%), sublobar resection (11.7%), conventional radiation (14.8%), observation (12.6%), and SABR (1.1%). In Cox regression with median follow up of 3.2 years, SABR was associated with the lowest risk of death within six months of diagnosis (HR 0.48; 95%CI 0.38–0.63; referent is lobectomy). After six months, lobectomy was associated with the best overall and disease-specific survival. In the propensity-score matched analysis, survival after SABR was similar to lobectomy (HR 0.71; 95%CI 0.45–1.12). Conventional radiation and observation were associated with poor outcomes in all analyses. Conclusions In this population-based experience, lobectomy was associated with the best long-term outcomes in fit elderly patients with early-stage NSCLC. Exploratory analysis of SABR early-adopters suggests efficacy comparable to surgery in select populations. Evaluation of these therapies in randomized trials is urgently needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijrobp.2012.07.2354

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 250

Metadata

Authors
Shirvani, S. M., Jiang, J., Chang, J. Y., Welsh, J. W., Gomez, D. R., Swisher, S., Buchholz, T. A., & Smith, B. D.
Venue
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Published
2012-12
Volume
84
Issue
5
Pages
1060-1070
ISSN
0360-3016 (ISSN-L)
OpenAlex
W2056221208
Cited by
250
References
2
FWCI
22.06
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly. https://app.cochat.ai/papers/10.1016/j.ijrobp.2012.07.2354
The paper
Shirvani, S. M., Jiang, J., Chang, J. Y., Welsh, J. W., Gomez, D. R., Swisher, S., Buchholz, T. A., & Smith, B. D. (2012). Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2012.07.2354

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.